<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Charles River Laboratories International, Inc. (CRL) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/crl/</link>
<description>Every dated entry in the public record on Charles River Laboratories International, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/crl/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Wed, 23 Sep 2026 00:00:00 +0000</lastBuildDate>
<item><title>Charles River Laboratories International, Inc.: Schedule 13G/A filed by FMR LLC, 10.2% of the class</title><link>https://greeksoup.ai/stocks/us/crl/holders/</link><guid isPermaLink="false">us:CRL:schedule-13:2026-09-08:18416ee338</guid><pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000031506626002294/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: short interest 2,535,053 shares at the 31 August 2026 settlement, 2.78 days to cover</title><link>https://greeksoup.ai/stocks/us/crl/short-interest/</link><guid isPermaLink="false">us:CRL:short-interest:2026-08-31:b7989d5139</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Foster James C (Director) sold 33,561 shares at $300.00 on 25 August 2026, $10.1 million</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-27:f04d746115</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000140/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Form 144, FOSTER JAMES C plans to sell 33,561 shares worth $10.1 million around 25 August 2026</title><link>https://greeksoup.ai/stocks/us/crl/planned-sales/</link><guid isPermaLink="false">us:CRL:planned-sale:2026-08-25:efdb41de25</guid><pubDate>Tue, 25 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000196922326000955/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Parisotto Shannon M (CEVP, Disc &amp; Safety Assessment) sold 2,039 shares at $294.12 on 19 August 2026, $599,711</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-20:9801f94610</guid><pubDate>Thu, 20 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000136/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Andrews Nancy C (Director) sold 573 shares at $285.24 on 18 August 2026, $163,443</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-20:ae1e5460a2</guid><pubDate>Thu, 20 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000134/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Form 144, Parisotto Shannon M plans to sell 2,039 shares worth $599,711 around 19 August 2026</title><link>https://greeksoup.ai/stocks/us/crl/planned-sales/</link><guid isPermaLink="false">us:CRL:planned-sale:2026-08-19:76bc58b734</guid><pubDate>Wed, 19 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000196922326000932/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Form 144, Nancy C Andrews plans to sell 573 shares worth $163,305 around 18 August 2026</title><link>https://greeksoup.ai/stocks/us/crl/planned-sales/</link><guid isPermaLink="false">us:CRL:planned-sale:2026-08-18:7992a189c4</guid><pubDate>Tue, 18 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000196922326000918/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: short interest 2,360,745 shares at the 14 August 2026 settlement, 2.22 days to cover</title><link>https://greeksoup.ai/stocks/us/crl/short-interest/</link><guid isPermaLink="false">us:CRL:short-interest:2026-08-14:81f896a18a</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Schedule 13G filed by Invesco Ltd., 6.2% of the class</title><link>https://greeksoup.ai/stocks/us/crl/holders/</link><guid isPermaLink="false">us:CRL:schedule-13:2026-08-13:0bbf597a1c</guid><pubDate>Thu, 13 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000091420826000275/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Girshick Birgit (Chief Executive Officer) sold 6,500 shares at $279.90 on 11 August 2026, $1.8 million</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-13:ae8b014df0</guid><pubDate>Thu, 13 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000132/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Parisotto Shannon M (CEVP, Disc &amp; Safety Assessment) sold 3,714 shares at $279.66 on 11 August 2026, $1.0 million</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-13:b897738b9d</guid><pubDate>Thu, 13 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000130/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Form 144, Parisotto Shannon M plans to sell 3,714 shares worth $1.0 million around 11 August 2026</title><link>https://greeksoup.ai/stocks/us/crl/planned-sales/</link><guid isPermaLink="false">us:CRL:planned-sale:2026-08-11:419c9cbd9b</guid><pubDate>Tue, 11 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000196922326000886/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Form 144, Girshick Birgit plans to sell 6,500 shares worth $1.8 million around 11 August 2026</title><link>https://greeksoup.ai/stocks/us/crl/planned-sales/</link><guid isPermaLink="false">us:CRL:planned-sale:2026-08-11:224d638961</guid><pubDate>Tue, 11 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000196922326000885/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Foster James C (Director) sold 28,733 shares at $275.00 on 10 August 2026, $7.9 million</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-11:a02bf6f02c</guid><pubDate>Tue, 11 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000126/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Form 144, FOSTER JAMES C plans to sell 28,733 shares worth $7.9 million around 10 August 2026</title><link>https://greeksoup.ai/stocks/us/crl/planned-sales/</link><guid isPermaLink="false">us:CRL:planned-sale:2026-08-10:ab32a255ba</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000196922326000874/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Knell Michael Gunnar (SVP, Finance and CAO) sold 1,274 shares at $259.07 on 6 August 2026, $330,055</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-10:1337ca2890</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Knell Michael Gunnar (SVP, Finance and CAO) sold 901 shares at $260.63 on 6 August 2026, $234,828</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-10:295c42a10e</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Knell Michael Gunnar (SVP, Finance and CAO) sold 810 shares at $261.45 on 6 August 2026, $211,774</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-10:2ab9f077c4</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Knell Michael Gunnar (SVP, Finance and CAO) sold 213 shares at $262.37 on 6 August 2026, $55,885</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-10:1c0d49935c</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Knell Michael Gunnar (SVP, Finance and CAO) sold 620 shares at $263.94 on 6 August 2026, $163,643</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-10:100d12a3f9</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Knell Michael Gunnar (SVP, Finance and CAO) sold 482 shares at $265.17 on 6 August 2026, $127,812</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-10:a8c1fc4094</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Knell Michael Gunnar (SVP, Finance and CAO) sold 404 shares at $258.53 on 6 August 2026, $104,446</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-10:cd9189c349</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Knell Michael Gunnar (SVP, Finance and CAO) sold 1,205 shares at $258.53 on 6 August 2026, $311,529</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-10:e854c59a4b</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Knell Michael Gunnar (SVP, Finance and CAO) sold 736 shares at $258.53 on 6 August 2026, $190,278</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-10:8cdef3f1fe</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000124/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Creamer Victoria L (EVP &amp; Chief People Officer) sold 4,179 shares at $259.16 on 6 August 2026, $1.1 million</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-10:84d6ad18b3</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000122/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Form 144, Victoria Creamer plans to sell 4,179 shares worth $1.1 million around 6 August 2026</title><link>https://greeksoup.ai/stocks/us/crl/planned-sales/</link><guid isPermaLink="false">us:CRL:planned-sale:2026-08-06:4bb0692374</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000196922326000853/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Form 144, Michael Knell plans to sell 6,645 shares worth $1.7 million around 6 August 2026</title><link>https://greeksoup.ai/stocks/us/crl/planned-sales/</link><guid isPermaLink="false">us:CRL:planned-sale:2026-08-06:4fbea5fe1d</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000196922326000852/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Schedule 13G/A filed by FMR LLC, 8.8% of the class</title><link>https://greeksoup.ai/stocks/us/crl/holders/</link><guid isPermaLink="false">us:CRL:schedule-13:2026-08-06:a8cff387a0</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000031506626001960/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Parisotto Shannon M (CEVP, Disc &amp; Safety Assessment) sold 5,046 shares at $263.00 on 5 August 2026, $1.3 million</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-08-06:79e9220c25</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000120/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc. Q2 FY2026 results: revenue $1.0 billion, net income -$1 million</title><link>https://greeksoup.ai/stocks/us/crl/results/fy2026-q2/</link><guid isPermaLink="false">us:CRL:result:2026-08-05:ce8353b4dc</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001100682&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/results/fy2026-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc. filed 10-Q: 10-q</title><link>https://greeksoup.ai/stocks/us/crl/filings/</link><guid isPermaLink="false">us:CRL:filing:2026-08-05:83ece3c5d1</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000118/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc. filed 8-K: results of operations</title><link>https://greeksoup.ai/stocks/us/crl/filings/</link><guid isPermaLink="false">us:CRL:filing:2026-08-05:f049828af7</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000115/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Form 144, Parisotto Shannon M plans to sell 5,046 shares worth $1.3 million around 5 August 2026</title><link>https://greeksoup.ai/stocks/us/crl/planned-sales/</link><guid isPermaLink="false">us:CRL:planned-sale:2026-08-05:9682edfa9f</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000196922326000848/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: short interest 3,419,974 shares at the 31 July 2026 settlement, 4.06 days to cover</title><link>https://greeksoup.ai/stocks/us/crl/short-interest/</link><guid isPermaLink="false">us:CRL:short-interest:2026-07-31:e9e4fec9f1</guid><pubDate>Fri, 31 Jul 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: short interest 3,343,526 shares at the 15 July 2026 settlement, 3.99 days to cover</title><link>https://greeksoup.ai/stocks/us/crl/short-interest/</link><guid isPermaLink="false">us:CRL:short-interest:2026-07-15:a2d604b4b5</guid><pubDate>Wed, 15 Jul 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Foster James C (Director) sold 75,000 shares at $225.00 on 29 June 2026, $16.9 million</title><link>https://greeksoup.ai/stocks/us/crl/insiders/</link><guid isPermaLink="false">us:CRL:insider:2026-07-01:f72483a484</guid><pubDate>Wed, 01 Jul 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000110068226000111/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: short interest 4,354,792 shares at the 30 June 2026 settlement, 4.26 days to cover</title><link>https://greeksoup.ai/stocks/us/crl/short-interest/</link><guid isPermaLink="false">us:CRL:short-interest:2026-06-30:acccdbd65c</guid><pubDate>Tue, 30 Jun 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Charles River Laboratories International, Inc.: Form 144, FOSTER JAMES C plans to sell 75,000 shares worth $16.9 million around 29 June 2026</title><link>https://greeksoup.ai/stocks/us/crl/planned-sales/</link><guid isPermaLink="false">us:CRL:planned-sale:2026-06-29:869870b320</guid><pubDate>Mon, 29 Jun 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1100682/000196922326000736/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/crl/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
